Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy, safety, and pharmacokinetics/pharmacodynamics of levodopa-carbidopa in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• L-Dopa/Carbidopa (levodopa-carbidopa)

Snippet

Sponsor: Osmotica Pharmaceutical US LLC | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED